Published in Diabetologia (Blher and colleagues, NCT04153929), this Phase 2 trial randomized 413 adults with type 2 diabetes on background metformin to survodutide across several once-weekly or twice-weekly dose groups, to placebo, or to open-label semaglutide up to 1.0 mg once weekly
Weight Loss Injections In the search for effective weight management solutions, two names have emerged as game-changers in the pharmaceutical landscape: Semaglutide (active ingredient in Ozempic and Wegovy) and Tirzepatide (active ingredient in Munjaro)
The agency also emphasized that the drug is most effective when taken in combination with a reduced-calorie diet and physical activity

Preferred Injection Sites : Lower abdomen (2-3 inches from navel) Upper thighs (outer quadrant) Upper arms (posterior aspect) Rotate injection sites to prevent lipodystrophy Injection Equipment : 30-31 gauge insulin syringes 0.5-1ml syringe capacity 12.7mm (1/2 inch) needle length Reconstitution Protocol AOD 9604 typically requires reconstitution from lyophilized powder: Use bacteriostatic water (0.9% benzyl alcohol) Add 2ml bacteriostatic water to 5mg vial Results in 2.5mg/ml concentration Gently swirl until completely dissolved Store reconstituted solution refrigerated Storage Requirements Unreconstituted : Room temperature, protect from light Reconstituted : Refrigerate at 2-8C (36-46F) Stability : Use within 28 days of reconstitution Transport : Keep cool during travel, avoid freezing Optimal Timing and Cycling Strategies Timing for Maximum Effectiveness Morning Administration : Primary recommendation for single daily dosing
The enigmatic persistence of anorexia nervosa
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength